0001047469-08-006205 Sample Contracts

PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENT (CEO)

Change of Control Agreement • May 8th, 2008 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Change of Control Agreement
• Filed
  May 8th, 2008
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Amended and Restated Change of Control Agreement (CEO) (this “Agreement”), dated as of March 3, 2008, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (formerly known as NeoRx Corporation and as supplemented by Section 13, the “Company”), and GERALD MCMAHON (the “Executive”).

PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED KEY EXECUTIVE SEVERANCE AGREEMENT

Key Executive Severance Agreement • May 8th, 2008 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Key Executive Severance Agreement
• Filed
  May 8th, 2008
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Amended and Restated Key Executive Severance Agreement (this “Agreement”), dated as of March 3, 2008, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (formerly known as NeoRx Corporation and as supplemented by Section 10, the “Company”), and RONALD MARTELL (the “Executive”).

Contract

Ingredient Manufacturing Agreement • May 8th, 2008 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Ingredient Manufacturing Agreement
• Filed
  May 8th, 2008
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

*** Indicates confidential material that has been omitted pursuant to a Confidential Treatment Request filed with the Securities and Exchange Commission. A complete copy of this agreement has been separately filed with the Securities and Exchange Commission.